LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹43 Cr | ₹27 Cr | ₹20 Cr | ₹18 Cr | ₹8.67 Cr |
What is the latest Sundry Debtors ratio of LYKA LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹43 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹8.67 Cr |
How is Sundry Debtors of LYKA LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹43 Cr | 59.59 | |
| Mar2024 | ₹27 Cr | 34.12 | |
| Mar2023 | ₹20 Cr | 9.07 | |
| Mar2022 | ₹18 Cr | 112.79 | |
| Mar2021 | ₹8.67 Cr | - | |
Compare Sundry Debtors of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹211.2 Cr | -4.5% | 1.7% | -47.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -4.5% |
1.7% |
-47.2% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses